Navigation Links
Dreamcloud Productions Says New Sound-Reducing Sleep Mask May Be World’s Best Sleep Aid
Date:12/13/2012

tar Transformer. De Cordova dropped the single piece design in favor of a ‘three easy pieces’ format, letting the user easily mix and match the mask parts they want to use at the moment. For example, the Nap Star can be worn as a simple sleep mask without the pillow, or the pillow minus the mask. Using all pieces, Nap Star transforms to the ideal sleep combo – blocking light, pillowing the head, muffling sound, and staying in place, all totally adjustable.

Nap Star and the Dreamhelmet still share many features. Both are hand-sewn and contain sound-blocking material, and both convert to pillows that can be used alone for sleeping or back support. They are also hypoallergenic and non-irritating, with 100% cotton fabric touching the face. They have no straps or connections around the head to tangle in hair or cause annoying lumps. Both have a chin strap, which keeps the mask on the face of the user. Sleep masks slipping off the face at night have been a common complaint with users. De Cordova’s patented products are the only sleep masks in the world with a chin strap to solve this problem.

The Nap Star, however, has no secret pockets, nor does it convert to a muff. But these are non-sleep extra features which many customers do not need or use for sleeping at home, and eliminating them brought production costs down significantly. The resulting Nap Star is hence more esthetic and streamlined. The Nap Star still does plenty of transforming, but because of its simplified design, at $19.95, it sells for 1/3 less than the Dreamhelmet. Says de Cordova, "You get a good sleep mask and a lot more - for just the price of a good sleep mask".

The Nap Star was recently presented to the public on a trial basis on both eBay and Amazon websites, and most buyers seem enthusiastic about the new sleep mask concept.

The economical Nap Star Transformer, with its versatility, and all pieces, including expanding foam earplugs, inside a string tie
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
2. Disrupted Sleep May Raise Risk for Obesity, Diabetes: Study
3. Depressed moms behavior may play role in infants sleep problems
4. Depressed Moms May Hinder Babies Sleep
5. Poor Sleep Heightens Ringing Ear Disease Symptoms: Study
6. Adjusting Your Attitude About Chronic Pain May Help You Sleep
7. Excessive sleepiness may be cause of learning, attention and school problems
8. Study: Kids Who Sleep in Parents Bed Less Likely to Be Overweight
9. Sleepwalking in Adults More Common Than Thought
10. Pediatric epilepsy impacts sleep for the child and parents
11. Parents Often Lose Sleep Over Childs Epilepsy, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® ... medical devices, announced its only mission and research focus: Water Life Science®. In ... Kleyne, body water evaporation is becoming dangerously accelerated. As a result of the ...
(Date:9/4/2015)... ... September 04, 2015 , ... The USC Eye Institute is proud to announce ... Doximity. Faculty, residents and staff are honored to have contributed to the success ... our ophthalmology residency program. Our faculty places a high priority on our educational programs ...
(Date:9/4/2015)... ... September 04, 2015 , ... The conference program ... Hollywood, Florida October 9-10, 2015 at the Diplomat Resort & Spa has been ... doctors and researchers at the top of their field and will be presenting ...
(Date:9/4/2015)... ... 04, 2015 , ... Having access to a doctor can sometimes be a ... of unnecessary emergency room visits which affects hospitals’ abilities to provide quality service to ... a solution to alleviate this problem has recently presented itself, the new telemedicine platform ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... its first neighborhood created specifically for adults with intellectual, developmental and acquired disabilities. ... area and feature 30 cottage or “pocket” homes. In this community, adults will ...
Breaking Medicine News(10 mins):Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4
... of Vulnerability Management and Operational Whitelisting and Discuss Today,s ... ... Scottsdale, Ariz. (PRWEB) August ... __title__ Vulnerability Management Solutions], a recognized, global leader in ...
... allergies aren,t avoiding the foods they know they shouldn,t eat. ... epinephrine as often as they should be. And instructors, roommates ... if a food-allergic student has a reaction. , These are ... of Michigan Health System. The research suggests that many college ...
... Scott Kornhauser,announced the appointment of Marquita Collins as ... than 20 years of,healthcare industry experience., Her ... of,Aptiv Technology Partners and Regional Operations Director for ... and managing the,entire professional services team and full ...
... NCST ; TSX: NCS), a developer and manufacturer of ... financial results for the second quarter 2008 on Tuesday, August ... 9:00 AM ET on Wednesday,August 13, 2008 to discuss the ... Date: Wednesday, ...
... nevirapine could have downside, study finds , , TUESDAY, Aug. ... used in developing countries to prevent transmission of ... breast milk and blood of mothers, a new Stanford ... the risk that they and their children will develop ...
... emphasize measurement gaps and harmonization, WASHINGTON, ... assessing,clinician performance that can promote higher quality ... endorsed 67 clinician-level consensus,standards relating to cancer ... by thousands of medical professionals who are ...
Cached Medicine News:Health News:Lumension Security To Showcase Vulnerability Management Expertise With Whitehatworld.com Webcast 2Health News:Lumension Security To Showcase Vulnerability Management Expertise With Whitehatworld.com Webcast 3Health News:Students with food allergies often not prepared 2Health News:Students with food allergies often not prepared 3Health News:NUCRYST Pharmaceuticals to Release Second Quarter 2008 Financial Results on Tuesday, August 12, 2008 2Health News:HIV Drug Might Spur Resistant Strains of Virus 2Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 2Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 3Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 4Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 5Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 6Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 7Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 8Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 9Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 10Health News:National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting 11
(Date:9/4/2015)... , September 4, 2015 ... announces that Hutchison MediPharma Limited ("HMP"), its drug ... the second proof-of-concept ("POC") trial of fruquintinib in ... ("NSCLC") in China .  The ... in meeting the primary efficacy endpoint of progression ...
(Date:9/3/2015)... India , Sept. 3, 2015  Cipla, a ... meet the everyday needs of all patients, today announced ... definitive agreements to acquire two US-based companies, InvaGen Pharmaceuticals ... to certain closing conditions, is valued at $550 million ... revenue from these transactions is over $200 million for ...
(Date:9/3/2015)... -- Report Details Ovarian Cancer Therapies ... and Emerging Opportunities What,s the future for treating ... forecasts those pharmaceutical revenues. There you find outlooks ... explore trends, results, treatments, R&D, and opportunities, seeing ... to 2025 at overall world market, submarket, product ...
Breaking Medicine Technology:Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6
... - Antigenics Inc.,(NASDAQ: AGEN) today announced additional ... therapeutic cancer vaccine,Oncophage(R) (vitespen). The end-of-study results, ... showed that in a substantial,subset of patients ... disease,recurrence, Oncophage demonstrated a clinically significant,improvement in ...
... product recently approved by FDA for long-term,maintenance ... formoterol fumarate provides improved lung function,comparable to ... and positive safety profile -- , NAPA, ... at the,International Conference of the American Thoracic ...
Cached Medicine Technology:Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 2Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 3Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 4Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 5Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7
...
The Tew cranial/spinal retractor is designed for posterior fossa or intraspinal microsurgery where retraction is required. Clinical applications are: Posterior fossa microsurgery and intraspinal micr...
The Budde Halo brain retractor is designed for use in all intercranial procedures where retraction of delicate brain tissue is required....
Love-Adson periosteal elevator, semi sharp, blade width 3/16" (5 mm), length 6 1/2" (165 mm)....
Medicine Products: